Strongbridge Biopharma plc SBBP
$ 2.0
1.52%
Strongbridge Biopharma plc Financial Ratios 2011-2024 | SBBP
Annual Financial Ratios Strongbridge Biopharma plc
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.4 | -3.2 | 6.9 | -2.2 | -1.0 | -1.8 | - | - | - | - |
P/S |
4.9 | 7.2 | 12.2 | 35.0 | - | - | - | - | - | - |
EV/EBITDA |
-2.1 | -1.7 | -1.3 | -4.7 | 0.0 | -0.6 | - | - | - | - |
PEG |
-0.24 | 0.01 | 0.06 | 0.06 | -0.07 | 0.01 | - | - | - | - |
P/B |
2.3 | 2.2 | 1.9 | -20.7 | 0.7 | 0.8 | - | - | - | - |
P/CF |
-4.0 | -3.5 | -2.6 | -5.4 | -1.5 | -2.0 | - | - | - | - |
ROE % |
-68.71 | -68.50 | 28.20 | 952.52 | -72.56 | -48.23 | - | - | - | - |
ROA % |
-37.22 | -42.04 | 18.70 | -109.20 | -35.34 | -44.78 | - | - | - | - |
ROCE % |
-43.18 | -68.40 | -53.53 | -57.98 | -28.71 | -46.65 | - | - | - | - |
DSO |
33.3 | 38.5 | 32.9 | 82.1 | - | - | - | - | - | - |
DIO |
182.0 | 190.3 | 361.3 | 125.8 | - | - | - | - | - | - |
DPO |
244.7 | 318.1 | 108.4 | 306.9 | - | - | - | - | - | - |
All numbers in USD currency